This interview features Magdalena Daccord, CEO of FH Europe Foundation, discussing key challenges and future directions in the management of familial hypercholesterolemia (FH). The conversation focuses on patient advocacy, early diagnosis, and the importance of international collaboration between clinicians, researchers, and policymakers. Special attention is given to emerging initiatives, including the Lp(a) International Task Force, and the role of patient networks in improving awareness and access to care.

---------------------------------------------------

Script-prep: Maria Cherska, Azin Kheirkhah, Svetlana Stoica

Interviewer: Maria Cherska, Svetlana Stoica